Xtant Medical to Present at the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase
Xtant Medical Holdings (NYSE American: XTNT), a global medical technology company specializing in spinal disorder treatments, has announced its participation in the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase. The event will take place from August 13-15, 2024 at the InterContinental Boston.
Sean Browne, President and CEO, and Scott Neils, CFO, will represent Xtant Medical at the conference. Browne is scheduled to present on Wednesday, August 14th at 11:00 a.m. Eastern. Investors and interested parties can access a video webcast of the presentation through the provided link.
This conference participation offers Xtant Medical an opportunity to showcase its surgical solutions and connect with potential investors and industry professionals.
Xtant Medical Holdings (NYSE American: XTNT), un'azienda globale di tecnologia medica specializzata nel trattamento dei disturbi spinali, ha annunciato la sua partecipazione alla 44ª Conferenza Annuale di Crescita & Vetrina di Aziende Private di Canaccord Genuity. L'evento si terrà dal 13 al 15 agosto 2024 all'InterContinental di Boston.
Sean Browne, Presidente e CEO, e Scott Neils, CFO, rappresenteranno Xtant Medical alla conferenza. Browne è programmato per presentare mercoledì 14 agosto alle 11:00 a.m. Eastern. Gli investitori e le parti interessate possono accedere a un webcast video della presentazione tramite il link fornito.
Questa partecipazione alla conferenza offre a Xtant Medical l'opportunità di mostrare le sue soluzioni chirurgiche e di connettersi con potenziali investitori e professionisti del settore.
Xtant Medical Holdings (NYSE American: XTNT), una empresa global de tecnología médica especializada en el tratamiento de trastornos de la columna vertebral, ha anunciado su participación en la 44ª Conferencia Anual de Crecimiento y Vitrina de Empresas Privadas de Canaccord Genuity. El evento se llevará a cabo del 13 al 15 de agosto de 2024 en el InterContinental de Boston.
Sean Browne, Presidente y CEO, y Scott Neils, CFO, representarán a Xtant Medical en la conferencia. Browne está programado para presentar el miércoles 14 de agosto a las 11:00 a.m. Eastern. Los inversores y partes interesadas pueden acceder a una transmisión web en video de la presentación a través del enlace proporcionado.
Esta participación en la conferencia ofrece a Xtant Medical la oportunidad de mostrar sus soluciones quirúrgicas y conectarse con posibles inversores y profesionales de la industria.
Xtant Medical Holdings (NYSE American: XTNT), 척추 질환 치료를 전문으로 하는 글로벌 의료 기술 회사가 Canaccord Genuity 제44회 연례 성장 회의 및 비상장 기업 전시회에 참여한다고 발표했습니다. 이 행사는 2024년 8월 13일부터 15일까지 인터컨티넨탈 보스턴에서 개최됩니다.
Sean Browne CEO와 Scott Neils CFO가 회의에서 Xtant Medical을 대표할 예정입니다. Browne은 2024년 8월 14일 수요일 오전 11:00 (동부 표준시)에 발표할 예정입니다. 투자자와 관심 있는 당사자는 제공된 링크를 통해 발표 영상을 시청할 수 있습니다.
이번 회의 참여는 Xtant Medical이 자사의 수술 솔루션을 선보이고 잠재 투자자 및 업계 전문가들과 연결될 수 있는 기회를 제공합니다.
Xtant Medical Holdings (NYSE American: XTNT), une entreprise mondiale de technologie médicale spécialisée dans les traitements des troubles de la colonne vertébrale, a annoncé sa participation à la 44e Conférence Annuelle de Croissance & Vitrine des Entreprises Privées de Canaccord Genuity. L'événement se déroulera du 13 au 15 août 2024 à l'InterContinental Boston.
Sean Browne, Président et CEO, et Scott Neils, CFO, représenteront Xtant Medical lors de la conférence. Browne est prévu de faire sa présentation le mercredi 14 août à 11h00, heure de l'Est. Les investisseurs et les parties intéressées peuvent accéder à un webcast vidéo de la présentation via le lien fourni.
Cette participation à la conférence offre à Xtant Medical l'opportunité de présenter ses solutions chirurgicales et de se connecter avec de potentiels investisseurs et professionnels de l'industrie.
Xtant Medical Holdings (NYSE American: XTNT), ein globales Medizintechnikunternehmen, das sich auf die Behandlung von Wirbelsäulenerkrankungen spezialisiert hat, hat seine Teilnahme an der 44. jährlichen Wachstums-Konferenz und privaten Unternehmensschau von Canaccord Genuity bekannt gegeben. Die Veranstaltung findet vom 13. bis 15. August 2024 im InterContinental Boston statt.
Sean Browne, Präsident und CEO, und Scott Neils, CFO, werden Xtant Medical auf der Konferenz vertreten. Browne wird voraussichtlich am Mittwoch, den 14. August um 11:00 Uhr Eastern präsentieren. Investoren und interessierte Parteien können einen Video-Webcast der Präsentation über den bereitgestellten Link abrufen.
Diese Teilnahme an der Konferenz bietet Xtant Medical die Möglichkeit, seine chirurgischen Lösungen zu präsentieren und mit potenziellen Investoren und Branchenfachleuten in Kontakt zu treten.
- None.
- None.
BELGRADE, MT / ACCESSWIRE / July 25, 2024 / Xtant Medical Holdings, Inc. (NYSE American:XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disorders, today announced that Sean Browne, President and Chief Executive Officer, and Scott Neils, Chief Financial Officer, will attend the Canaccord Genuity 44th Annual Growth Conference & Private Company Showcase being held August 13-15, 2024 at the InterContinental Boston, an IHG Hotel.
Sean Browne, President and Chief Executive Officer will present on Wednesday, August 14th at 11:00 a.m. Eastern.
A video webcast of the presentation will be available at: https://wsw.com/webcast/canaccord98/xtnt/2523378
About Xtant Medical Holdings, Inc.
Xtant Medical's mission of honoring the gift of donation so that our patients can live as full and complete a life as possible, is the driving force behind our company. Xtant Medical Holdings, Inc. (https://xtantmedical.com/) is a global medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Xtant people are dedicated and talented, operating with the highest integrity to serve our customers.
The symbols™ and ® denote trademarks and registered trademarks of Xtant Medical Holdings, Inc. or its affiliates, registered as indicated in the United States, and in other countries. All other trademarks and trade names referred to in this release are the property of their respective owners.
Investor Relations Contact
Brett Maas • Managing Partner, Hayden IR
brett@haydenir.com • (646) 536-7331
SOURCE: Xtant Medical Holdings
View the original press release on accesswire.com
FAQ
When is Xtant Medical (XTNT) presenting at the Canaccord Genuity Conference?
Who will be representing Xtant Medical (XTNT) at the Canaccord Genuity Conference?
Where can I watch Xtant Medical's (XTNT) presentation at the Canaccord Genuity Conference?
What is the date range for the Canaccord Genuity Conference that Xtant Medical (XTNT) is attending?
Where is the Canaccord Genuity Conference taking place that Xtant Medical (XTNT) is attending?
